玻璃膨胀室

The majority of nasal products are designed to generate droplets/particles with a mass median aerodynamic diameter (MMAD) of greater than 10 to 20 microns. This is to increase nasal deposition and minimise deposition in the lungs. However, most sprays deliver a proportion (typically <5%) of fine droplets in the <10 micron range. It is important to quantify this Fine Particle Dose (FPD) since it can penetrate beyond the nasal tract and into the lower respiratory tract or lungs, which may be undesirable. Cascade impactors are designed to capture particles in the range 0 to 10 microns and are widely used for this application.

Glass Expansion Chambers

The use of a cascade impactor together with a high volume expansion chamber is used to measure the amount of drug in small particles or droplets in respect of nasal sprays and aerosols. In accordance with the draft guidance, we offer a range of glass expansion chambers to meet these requirements. We offer 3 sizes:

  • 1 L chamber: to maximise drug deposition below the top stage of the impactor (i.e. for nasal aerosols)

  • 2 L chamber: to maximise aerosolisation and impactor deposition (i.e. for nasal sprays)

  • 5 L chamber: for powerful nasal sprays where increased space is required to generate full plume

相关服务

Related News & Resources

Copley推出新式流量传感器 —— 吸入制剂测试系统的专用装置。

27th June 2023

了解更多的详情

二合一解决方案Copley Impactor Genie™ IG 200i上市 —— 更快速、更高效的吸入制剂产品测试装置

25th April 2023

了解更多的详情

Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing

14th September 2022

了解更多的详情

New accessory completes Copley’s solution for automated nasal drug product testing

26th October 2021

了解更多的详情

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

22nd June 2021

了解更多的详情

Introducing Inhalytix™: a new solution for analysing and managing inhaler test data from Copley

18th March 2021

了解更多的详情

Copley introduces a comprehensive range for nasal product testing

12th March 2021

了解更多的详情

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

1st March 2021

了解更多的详情

DDD 2021 Respiratory eBook Profile

检视下载

Q&A: OINDPnews 2022

检视下载

RDD 2022 Poster: Chen et al.

检视下载

ONdrugDelivery Article: November 2021

检视下载

Manufacturing Chemist Feature: July 2021

检视下载